Insudiab is 90 capsules containing Soodium Butyrate in microgranules – the best available form of Sodium Butyrate, which is an effective pharmacological approach for type 2 diabetes and insulin resistance. 

Butyrate-mediated GLP-1 (intestinal hormone) secretion has been considered to be a major factor in the improvement of insulin sensitivity and decrease hepatic gluconeogenesis. It plays an important role in glucose homeostasis which makes this hormone an ideal candidate for the treatment of type 2 diabetes, insulin resistance, weight loss and cholesterol level reduction. 

The preparation can be used in all age groups without significant contraindications. Numerous studies from PubMed database have shown that sodium butyrate is effective without significant side effects.


  1. Henagan, Tara M et al. “Sodium butyrate epigenetically modulates high-fat diet-induced skeletal muscle mitochondrial adaptation, obesity and insulin resistance through nucleosome positioning.” British journal of pharmacology vol. 172,11 (2015): 2782-98.
  2. Gonzalez, Austin et al. “Sodium butyrate ameliorates insulin resistance and renal failure in CKD rats by modulating intestinal permeability and mucin expression.” Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association – European Renal Association vol. 34,5 (2019): 783-794.
  3. Zhang, Ling et al. “Sodium Butyrate Protects -Against High Fat Diet-Induced Cardiac Dysfunction and Metabolic Disorders in Type II Diabetic Mice.” Journal of cellular biochemistry vol. 118,8 (2017): 2395-2408.
  4. Larasati, Rahma Ayu et al. “The Role of Butyrate on Monocyte Migration and Inflammation Response in Patient with Type 2 Diabetes Mellitus.” Biomedicines vol. 7,4 74. 24 Sep. 2019, doi:10.3390/biomedicines7040074
Scroll to Top

This website uses cookies to ensure you get the best experience on our website.